LMG Life Sciences names A&O Firm to Watch – Intellectual Property
Related people
Headlines in this article
Related news and insights
News: 04 April 2024
Publications: 20 March 2024
Allen & Overy’s Nicole Daley on the rebound in M&A activity in the pharma industry
News: 15 March 2024
Allen & Overy advises Zendesk on its acquisition of AI-powered service automation leader Ultimate
Publications: 06 March 2024
Shifting Strategies in U.S. Intellectual Property Disputes: Lessons from 2023
LMG Life Sciences recognized A&O as the “Firm to Watch – Intellectual Property” for its 10th Annual LMG Life Sciences Awards Americas. The recognition of “Firm to Watch” exemplifies A&O’s growing U.S. Life Sciences practice, which notably enhanced its offerings in 2022 and 2021 with significant life sciences partner hires and includes an East Coast expansion in Boston.
Elizabeth Holland, Head of A&O’s U.S. Life Sciences and IP Litigation practices, notes, “We are honored to receive the LMG Life Sciences ‘Firm to Watch’ award. This recognition underscores the amazing growth in our IP litigation practice as we continue to represent leading innovators in the life sciences sector.”
A&O’s U.S. Life Sciences Intellectual Property practice combines in-depth technical and industry knowledge, extensive first chair trial experience and a strong global network. The team provides innovative solutions to the world’s leading life sciences businesses, defending clients’ interests in patent and other IP litigation, as well as handling complex transactions in which IP plays a key role.
The LMG Life Sciences Awards Americas program highlights the top firms in the industry leading innovating and challenging legal work across the U.S. and Canada. Research for the publication is based on work highlights along with peer and client feedback.